Matrix metalloproteinase-3 gene polymorphism and dilatative pathology of ascending thoracic aorta

Medicina

Volumn 44, Issue 5, 2008, Pages 386-391

  Lesauskaite, Vaiva ^a   Šinkunaite, Giedre ^a   Benetis, Rimantas ^a   Grabauskas, Vilius ^a   Vaškelyte, Jolanta ^a   Smalinskiene, Alina ^a   Šimonyte, Sandrita ^a   Jariene, Giedre ^a   Tatarunas, Vacis ^a   Klumbiene, Jurate ^a   Petkevičiene, Janina ^a   Kinduris, Šarunas ^a   Giedraitis, Saulius ^a   Sakalauskas, Juozas ^a   Bolys, Ramunas ^a   Širvinskas, Edmundas ^a   Lenkutis, Tadas ^a   Pangonyte, Dalia ^a  

^a KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

Author keywords

Aneurysm; Gene polynorphism; Matrix metalloproteinase 3; Thoracic aorta

Indexed keywords

DNA; STROMELYSIN;

ADULT; AGE; AGED; ALLELE; ARTICLE; COMPARATIVE STUDY; DISSECTING ANEURYSM; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; NONPARAMETRIC TEST; PATHOLOGY; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; THORACIC AORTA; THORACIC AORTA ANEURYSM;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALLELES; ANEURYSM, DISSECTING; AORTA, THORACIC; AORTIC ANEURYSM, THORACIC; DNA; FEMALE; GENOTYPE; HUMANS; MALE; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEX FACTORS; STATISTICS, NONPARAMETRIC;

EID: 45749151552     PISSN: 1010660X     EISSN: None     Source Type: Journal    
DOI: 10.3390/medicina44050050     Document Type: Article

References (30)

1. Lesauskaite V, Tanganelli P, Sassi C, Neri E, Diciolla F, Ivanoviene L, et al. Smooth muscle cells of the media in the dilatative pathology of ascending thoracic aorta: Morphology, immunoreactivity for osteopontin, matrix metalloproteinases, and their inhibitors. Hum Pathol 2001;32:1003-11.
2. Towbin JA, Casey B, Belmont J. The molecular basis of vascular disorders. Am J Hum Genet 1999;64:678-84.
3. Silence J, Lupu F, Collen D, Lijnen HR. Persistence of atherosclerotic plaque but reduced aneurysm formation in mice with stromelysin-1 (MMP-3) gene inactivation. Arterioscler Thromb Vasc Biol 2001;21(9):1440-5.
4. Kamijima T, Isobe M, Suzuki J, Fukui D, Arai M, Urayama H, et al. Enhanced embryonic nonmuscle myosin heavy chain isoform and matrix metalloproteinase expression in aortic abdominal aneurysm with rapid progression. Cardiovasc Pathol 1999;8(5):291-5.
5. Sternlicht M, Werb Z. How matrix metalloproteinases regulate cell behaviour. Annu Rev Cell Dev Biol 2001;17:463-516.
6. Zhang J, Jin X, Fang S, Li Y, Wang R, Guo W, et al. The functional SNP in the matrix metalloproteinase-3 promoter modifies susceptibility and lymphatic metastasis in esophageal squamous cell carcinoma but not in gastric cardiac adenocarcinoma. Carcinogenesis 2004;25(12):2519-24.
7. Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T. Regulation of matrix metalloproteinases: An overview. Mol Cell Biochem 2003;253:269-85.
8. Creemers EEJM, Cleutjens J, Smits J, Daemen M. Matrix metalloproteinase inhibition after myocardial infarction: A new approach to prevent heart failure? Circ Res 2001;89:201-10.
9. Spinale FG. Matrix metalloproteinases: Regulation and dysregulation in the failing heart. Circ Res 2002;90:520-30.
10. Ye S. Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome. Cardiovascular Research 2006;69:636-45.
11. Deguara J, Burnand KG, Berg J, Green P, Lewis CM, Chinien G, et al. An increased frequency of the 5A allele in the promoter region of the MMP3 gene is associated with abdominal aortic aneurysms. Hum Mol Genet 2007;16(24):3002-07.
12. Ghilardi G, Biondi L, DeMonti M, Turri O, Guagnellini E, Scorza R. Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with carotid artery stenosis. Stroke 2002;33:2408-12.
13. Kim JS, Park HY, Kwon JH, Im EK, Choi D, Jang Y, et al. The roles of stromelysin-1 and the gelatinase B gene polymorphism in stable angina. Yonsei Med J 2002;43(4):473-81.
14. Yamada Y, Izawa H, Ichihara S, Takatsu F, Ishihara H, Hirayama H, et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 2002; 347(24):1916-23.
15. Liu PY, Li YH, Chan SH, Lin LJ, Wu HL, Shi GY, et al. Genotype-phenotype association of matrix metalloproteinase-3 polymorphism and its synergistic effect with smoking on the occurrence of the acute coronary syndrome. Am J Cardiol 2006;98:1012-17.
16. Medley TL, Kingwell BA, Gatzka CD, Pillay P, Cole TJ. Matrix metalloproteinase-3 genotype contributes to age-related aortic stiffening through modulation of gene and protein expression. Circ Res 2003;92:1254-61.
17. Grabauskas V, Misevičiene I, Klumbiene J, Petkevičiene J, Milašauskiene Z, Plieskiene A, et al. Prevalence of dyslipidemias among Lithuanian rural population (CINDI program). Medicina (Kaunas) 2003;39(12):1215-22.
18. Sepp R, Szabo I, Uda H, Sakamoto H. Rapid techniques for DNA extraction from routinely processed archival tissue for use in PCR. J Clin Pathol 1994;47:318-23.
19. Shi SR, Cote R J, Wu L, Liu C, Datar R, Shi Y, et al. DNA Extraction from archival formalin-fixed, paraffin-embedded tissue sections based on the antigen retrieval principle: Heating under the influence of pH. J Histochem Cytochem 2002;50(8): 1005-11.
20. Thompson RW. Reflections on the pathogenesis of abdominal aortic aneurysms. Cardiovasc Surg 2002;10:389-94.
21. Taketani T, Imai Y, Morota T, Maemura K, Morita H, Hayashi D, et al. Altered patterns of gene expression specific to thoracic aortic aneurysms. Int Heart J 2005;46(2):65-77.
22. Absi TS, Thoralf M, Sundt III, William S, Moon M, Lee JK, et al. Altered patterns of gene expression distinguishing ascending aortic aneurysms from abdominal aortic aneurysms: Complementary DNA expression profiling in the molecular characterization of aortic disease. J Thorac Cardiovasc Surg 2003;126:344-57.
23. Ye S, Eriksson P, Hamsten A, Kurkinen M, Humphries SE, Henney AM. Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem 1996;271(22):13055-60.
24. Yoon S, Tromp G, Vongpunsawad S, Ronkainen A, Juvonen T, Kuivaniemi H. Genetic analysis of MMP3, MMP9 and PAI1 in Finnish patients with abdominal aortic or intracranial aneurysms. Biochem Biophys Res Commun 1999;265:563-8.
25. Humphries SE, Martin S, Cooper J, Miller G. Interaction between smoking and the stromelysin-1 (MMP3) gene 5A/6A promoter polymorphism and risk of coronary heart disease in healthy men. Ann Hum Genet 2002;66(Pt 5-6):343-52.
26. Ogata T, Shibamura H, Tromp G, Sinha M, Goddard KAB, Sakalihasan N, et al. Genetic analysis of polymorphisms in biologically relevant candidate genes in patients with abdominal aortic aneurysms. J Vasc Surg 2005;41(6):1036-42.
27. Samnegard A, Silveira A, Lundman P, Boquist S, Odeber J, Hulthe J, et al. Serum matrix metalloproteinase-3 concentration is influenced by MMP-3) 1612 5A/6A promoter genotype and associated with myocardial infarction. J Intern Med 2005;258:411-9.
28. Lamblin N, Bauters C, Hermant X, Lablanche JM, Helbecque N, Amouyel P. Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease. JACC 2002;40: 43-8.
29. Krippl P, Langsenlehner U, Renner W, Biuki BY, Koppel H, Leithner A, et al. The 5A/6A polymorphism of the matrix metalloproteinase 3 gene promoter and breast cancer. Clin Cancer Res 2004;10:3518-20.
30. Terashima M, Akita H, Kanazawa K, Inoue N, Yamada S, Ito K, et al. Stromelysin promoter 5A/6A polymorphism is associated with acute myocardial infarction. Circulation 1999;99: 2717-19.